Literature DB >> 17113969

Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.

Henry M Feder1, Micha Abeles, Megan Bernstein, Diane Whitaker-Worth, Jane M Grant-Kels.   

Abstract

Most patients with erythema migrans, the pathognomonic rash of Lyme disease, do not recall a deer tick bite. The rash is classically 5 to 68 cm of annular homogenous erythema (59%), central erythema (30%), central clearing (9%), or central purpura (2%). Serologic testing is not indicated for patients with erythema migrans, because initially, the result is usually negative. Successful treatment of a patient with erythema migrans can be accomplished with 20 days of oral doxycycline, amoxicillin, or cefuroxime axetil. Patients with Lyme arthritis usually present with a mildly painful swollen knee. Patients with Lyme arthritis have markedly positive serology and can usually be successfully treated with 28 days of oral doxycycline or amoxicillin. Some patients may have persistent effusion despite 4 to 8 weeks of antibiotics and may need synovectomy. Persistent effusion is not due to persistent infection. Antibiotic therapy for more than 8 weeks for patients with Lyme disease is not indicated. Chronic Lyme disease due to antibiotic resistant infection has not been demonstrated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113969     DOI: 10.1016/j.clindermatol.2006.07.012

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  8 in total

1.  Unique expression of chronic Lyme disease and Jarisch-Herxheimer reaction to doxycycline therapy in a young adult.

Authors:  Chad Haney; Milap C Nahata
Journal:  BMJ Case Rep       Date:  2016-07-20

2.  U.S. healthcare providers' experience with Lyme and other tick-borne diseases.

Authors:  Meghan E Brett; Alison F Hinckley; Emily C Zielinski-Gutierrez; Paul S Mead
Journal:  Ticks Tick Borne Dis       Date:  2014-04-06       Impact factor: 3.744

Review 3.  Lyme disease and the orthopaedic implications of lyme arthritis.

Authors:  Brian G Smith; Aristides I Cruz; Matthew D Milewski; Eugene D Shapiro
Journal:  J Am Acad Orthop Surg       Date:  2011-02       Impact factor: 3.020

4.  Emerging incidence of Lyme borreliosis, babesiosis, bartonellosis, and granulocytic ehrlichiosis in Australia.

Authors:  Peter J Mayne
Journal:  Int J Gen Med       Date:  2011-12-16

5.  A prospective study among patients presenting at the general practitioner with a tick bite or erythema migrans in The Netherlands.

Authors:  Agnetha Hofhuis; Tineke Herremans; Daan W Notermans; Hein Sprong; Manoj Fonville; Joke W B van der Giessen; Wilfrid van Pelt
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

6.  Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue.

Authors:  Peter J Mayne
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-07-05

7.  Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.

Authors:  Samuel Shor; Christine Green; Beatrice Szantyr; Steven Phillips; Kenneth Liegner; Joseph Jr Burrascano; Robert Bransfield; Elizabeth L Maloney
Journal:  Antibiotics (Basel)       Date:  2019-12-16

8.  Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi.

Authors:  Richard I Horowitz; Krithika Murali; Gauri Gaur; Phyllis R Freeman; Eva Sapi
Journal:  BMC Res Notes       Date:  2020-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.